The global glaucoma surgery devices market size was valued at USD 1.8 billion in 2023, driven by the increasing incidence of glaucoma across the globe. The market is expected to grow at a CAGR of 14.5% during the forecast period of 2024-2032, with the values likely to rise from USD 2.1 billion in 2024 to USD 6.1 billion by 2032.
Glaucoma is a set of eye diseases that can cause blindness and vision loss by damaging the optic nerve. It is caused by increased intraocular pressure in your eyes. Open-angle glaucoma and angle-closure glaucoma are the two main types of glaucoma.
Lowering the intraocular pressure to reduce the complication from accelerating is the main method to treat glaucoma. It can be done through medications, eye drops, laser surgery or minimally invasive glaucoma surgeries.
Glaucoma is a major cause of irreversible vision loss, projected to affect around 111.8 million people by 2040. Traditional approaches for addressing glaucoma involve medications, filtration surgery, or laser treatments, such as trabeculectomy. Nevertheless, poor tolerability and compliance are often associated with medications. Therefore, there has been an increasing preference towards using minimally invasive devices, which has fuelled the glaucoma surgery devices market demand.
Glaucoma surgery devices have observed notable progress with the introduction of innovative technologies characterized by an ab interno corneal incisional approach. These advancements emphasize offering minimal trauma, enhanced safety, and faster recovery for patients. For instance, devices like iStent Inject, feature a reduced size compared to its predecessor. It also enables the simultaneous implantation of two stents. In addition, Streamline by New World Medical and Hydrus by Alcon, are other newly introduced minimally invasive devices.
Non-penetrating glaucoma surgeries (NPGS), like deep sclerectomy and canaloplasty, have emerged as a safer and still effective way to reduce IOP in patients with more advanced glaucoma. In addition, the increasing involvement of prominent healthcare companies in ophthalmology is also driving the glaucoma surgery devices market growth. Ciliatech has announced their new class of implant called CID (Cilio-scleral Inter-positioning Device) to help reduce the IOP without entering the eye’s anterior chamber.
Market Breakup by Surgery Type
Market Breakup by Products
Market Breakup by End User
Market Breakup by Region
The increasing incidence of glaucoma has led to the development of several initiatives by government, non-profit and key healthcare companies to spread awareness on early diagnosis of the disease. In March 2023, ENTOD Eye Health Foundation launched a glaucoma awareness campaign in India. This campaign also conducted screenings in major Indian states. Such efforts are set to fuel substantial glaucoma surgery devices market value, not only in India, but the Asia Pacific region as well.
Similarly, Bausch + Lomb Corp., along with the Glaucoma Research Foundation, launched a campaign called Scree, Protect, Cure in the United States. This initiative can be considered highly important as the United States has been hugely affected by the illness in the historic period. We can also expect the region to lead the glaucoma surgery devices market share as it has a robust healthcare system and is home to several healthcare companies.
We can also anticipate Europe to experience noteworthy growth during the forecast period. This can be attributed to the increasing geriatric population and the growing adoption, as well as the integration of advanced technologies into the healthcare system. The accessibility and affordability of medical facilities in the region further solidifies its standing in the market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Surgery Type||
|Breakup by Products||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Glaucoma Surgery Devices Market Overview
3.1 Global Glaucoma Surgery Devices Market Historical Value (2017-2023)
3.2 Global Glaucoma Surgery Devices Market Forecast Value (2024-2032)
4 Global Glaucoma Surgery Devices Market Landscape
4.1 Global Glaucoma Surgery Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Glaucoma Surgery Devices: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Glaucoma Surgery Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Glaucoma Surgery Devices Market Segmentation
6.1 Global Glaucoma Surgery Devices Market by Surgery Type
6.1.1 Market Overview
6.1.2 Conventional Glaucoma Surgeries
6.1.3 Minimally Invasive Glaucoma Surgeries
6.2 Global Glaucoma Surgery Devices Market by Products
6.2.1 Market Overview
6.2.2 Implants and Stents
6.2.3 Glaucoma Drainage Devices
6.2.4 Glaucoma Laser Devices
6.3 Global Glaucoma Surgery Devices Market by End User
6.3.1 Market Overview
6.3.3 Surgical Centres
6.4 Global Glaucoma Surgery Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Glaucoma Surgery Devices Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Glaucoma Surgery Devices Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Glaucoma Surgery Devices Market
9.1 Market Share by Country
10 Latin America Glaucoma Surgery Devices Market
10.1 Market Share by Country
11 Middle East and Africa Glaucoma Surgery Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Abbvie Inc. (Allergan)
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.2 Alcon Inc
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.3 Glaukos Corporation
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.4 Johnson & Johnson (Abbott Medical Optics)
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.5 iStar Medical SA
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.6 Lumibird Medical (Ellex Medical Lasers Ltd)
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.7 Lumenis Ltd
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.8 New World Medical, Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.9 Santen Pharmaceutical Co. Ltd
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.10 Topcon Corporation
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 1.8 billion in 2023, driven by the increasing incidence of glaucoma across the globe.
The market is anticipated to grow at a CAGR of 14.5% during the forecast period of 2024-2032, likely to reach a market value of USD 6.1 billion by 2032.
The increasing preference for using minimally invasive devices to use in a glaucoma surgery has led to increased market demand.
Major market trends include the advent of new technologies and devices to improve the efficacy of surgical treatment. For instance, iStent Inject, features a reduced size compared to its predecessor.
they are used in conventional as well as minimally invasive glaucoma surgeries.
It includes implants & stents, glaucoma drainage devices and glaucoma laser devices.
Major end users include hospitals, and surgical centers.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Abbvie Inc. (Allergan), Alcon Inc, Glaukos Corporation, Johnson & Johnson (Abbott Medical Optics), iStar Medical SA, Lumibird Medical (Ellex Medical Lasers Ltd), Lumenis Ltd., New World Medical, Inc., Santen Pharmaceutical Co. Ltd, and Topcon Corporation.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.